The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 2.00 (0.37%)
Spread: 3.00 (0.556%)
Open: 533.00
High: 549.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

11 Jan 2013 07:00

RNS Number : 3043V
Polar Capital Holdings PLC
11 January 2013
 

11 January 2013

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

 

As at 31 December 2012 the Group's AUM have increased by 18% to $6.02bn from the $5.08bn reported at 31 March 2012 and have increased by 42% from the figure of $4.24bn reported at 31 December 2011.

 

The table below sets out the movements in the Group's AUM over the nine month period:

 

AUM movement

Nine months to 31 December 2012

Long only funds

$m

Hedge funds

$m

Total

$m

As at 31 March 2012

$4,365m

$718m

$5,083m

Net subscriptions

$842m

$81m

$923m

Market movement and performance

$(19)m

$34m

$15m

Total AUM at 31 December 2012

$5,188m

$833m

$6,021m

 

 

Comment

 

In October 2012 we reported that in our first half year, to September 2012, the Group had received $405m of net inflows. It is encouraging to report that the positive flows have continued with a further $518m of net inflows being received in our third quarter, across a range of strategies, taking the year to date net inflows up to $923m.

 

Assuming market conditions do not deteriorate, we are well positioned to continue to grow our AUM in 2013.

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 11

£m

Year to

31 Mar 12

(year-end)

£m

Nine months to

31 Dec 12

£m

Received

£3.7m

£4.1m

£5.1m

Accrued but not yet earned in funds with year ends on or before the financial year end

£0.3m

n/a

£0.3m

Total net performance fees

£4.0m

£4.1m

£5.4m

 

 

 

 

 

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Broker

Simon Bridges

Cameron Duncan

+44 (0)20 7523 8000

 

F T I Consulting

Ed Gascoigne-Pees

Jack Hickey

+44 (0)20 7269 7132

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKFEFEKDEFF
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.